SEC filing record
Primary Source · SEC.gov

Anuncia Medical, Inc.

2024 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalInvestors increasedForm D/A · 2025-11-219 events: 3 investors increased, 3 sold increased, 2 offering upsizedLast filing 2025-11-21

Raised

$14M

Investors

87

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Anuncia Medical, Inc. is a Delaware corporation that first filed a Form D on October 25, 2021 and most recently amended it on November 21, 2025 in the Biotechnology industry group. The offering claims Rule 506(b) and covers equity. Anuncia Medical, Inc. reported $13,908,008 sold from 87 investors of a $16,442,486 total offering as of the Form D filed November 21, 2025. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names U.S. Boston Capital Corporation (CRD 5251), associated with None as the recipient of sales compensation soliciting in all states. Sales commissions are reported as $0 and finders' fees as $66,450. Form D allows these to be estimates. The issuer's address of record is 1355 N. Scottsdale Rd, Suite 370, Scottsdale, AZ 85257.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001889938
Entity NameAnuncia Medical, Inc.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address1355 N. Scottsdale Rd, Suite 370, Scottsdale, AZ 85257
Phone(513) 500-6736
Industry / Fund TypeBiotechnology
Securities TypeEquity
First Sale DateAugust 30, 2024
Filing DateNovember 21, 2025
Accession Number0001889938-25-000002
Total Offering Amount$16,442,486
Total Amount Sold$13,908,008
Amount Remaining$2,534,478
Total Investors87
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$0 (to U.S. Boston Capital Corporation)
Finders' Fees$66,450
Revenue RangeDecline to Disclose
State (Issuer Address)AZ
Amendment Count9 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

9

latest Nov 21, 2025

Critical / warning

0 / 0

0 watch · 9 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

3

lapsed, dark, raising

Latest event Sold increase · Nov 21, 2025

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 9 filing events with values and deltas, latest 2025-11-21, and alerts on the next one
  • 3 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Elsa Abruzzo

Executive Officer, Director · SCOTTSDALE, AZ

PJ Anand

Director · SCOTTSDALE, AZ

Richard Upton

Director · SCOTTSDALE, AZ

David Donabedian

Director · SCOTTSDALE, AZ

Edgar D Janotta

Director · SCOTTSDALE, AZ

Stephen D Oesterle

Director · SCOTTSDALE, AZ

Stanton D Rowe

Director · SCOTTSDALE, AZ

Ghassan D Kassab

Director · SCOTTSDALE, AZ

Darryl D Baker

Executive Officer · SCOTTSDALE, AZ

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

U.S. Boston Capital CorporationCRD 5251 on BrokerCheck

Associated broker-dealer: None · Lincoln, MA · Soliciting in all states

Questions About Anuncia Medical, Inc.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Anuncia Medical, Inc.?

Anuncia Medical, Inc. is a Delaware corporation that filed a Form D with the SEC on November 21, 2025 in the Biotechnology industry group. The filing claims Rule 506(b) for an offering of equity.

Is Anuncia Medical, Inc. legit?

AltStreet does not rate legitimacy; it reports the public record. Anuncia Medical, Inc. filed a Form D with the SEC on November 21, 2025 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $13,908,008 sold to 87 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Anuncia Medical, Inc. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Anuncia Medical, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Anuncia Medical, Inc. raised?

Anuncia Medical, Inc. reported $13,908,008 sold from 87 investors of a $16,442,486 total offering as of the Form D filed November 21, 2025.

Who can invest in Anuncia Medical, Inc.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Anuncia Medical, Inc.?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Anuncia Medical, Inc. and how are they paid?

The Form D names U.S. Boston Capital Corporation (CRD 5251), associated with None as the recipient of sales compensation soliciting in all states. Sales commissions are reported as $0 and finders' fees as $66,450. Form D allows these to be estimates.

Who is behind Anuncia Medical, Inc.?

The Form D lists 9 related persons: Elsa Abruzzo, executive officer, director; PJ Anand, director; Richard Upton, director; David Donabedian, director; Edgar D Janotta, director; Stephen D Oesterle, director; Stanton D Rowe, director; Ghassan D Kassab, director, and 1 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Anuncia Medical, Inc. located?

The issuer's address on its SEC filings is 1355 N. Scottsdale Rd, Suite 370, Scottsdale, AZ 85257. Its phone number of record is (513)-500-6736. It is organized under the laws of Delaware.

How long is the Anuncia Medical, Inc. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 6 amendments are on record for this CIK.

What is Anuncia Medical, Inc.'s revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.